Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway.

Lin J, Zhou J, Xu W, Zhong X, Hong Z, Peng J.

Exp Ther Med. 2013 May;5(5):1293-1300. Epub 2013 Mar 15.

2.

Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway.

Lin J, Zhou J, Xu W, Hong Z, Peng J.

Exp Ther Med. 2014 Jul;8(1):118-124. Epub 2014 May 19.

3.

Inhibition of the signal transducer and activator of transcription 3 signaling pathway by Qianliening capsules suppresses the growth and induces the apoptosis of human prostate cells.

Lin J, Zhou J, Zhong X, Hong Z, Peng J.

Mol Med Rep. 2015 Mar;11(3):2207-14. doi: 10.3892/mmr.2014.2946. Epub 2014 Nov 13.

PMID:
25394909
4.

Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis.

Zheng H, Xu W, Lin J, Peng J, Hong Z.

Mol Med Rep. 2013 Mar;7(3):848-54. doi: 10.3892/mmr.2013.1265. Epub 2013 Jan 7.

PMID:
23314795
5.

Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo.

Zhong X, Lin J, Zhou J, Xu W, Hong Z.

Mol Med Rep. 2015 Aug;12(2):1699-708. doi: 10.3892/mmr.2015.3566. Epub 2015 Mar 27.

6.

miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia.

Liu L, Wan Y, Shen A, Zhao J, Lin J, Zhong X, Zhang Y, Hong Z.

Evid Based Complement Alternat Med. 2015;2015:365484. doi: 10.1155/2015/365484. Epub 2015 Jul 30.

7.

Qianliening capsule () inhibits human prostate cell growth via induction of mitochondrion-dependent cell apoptosis.

Hong ZF, Lin JM, Zhong XY, Li Y, Zhou JH, Xu W, Peng J.

Chin J Integr Med. 2012 Nov;18(11):824-30. doi: 10.1007/s11655-012-1264-y. Epub 2012 Oct 20.

PMID:
23086486
8.

Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population.

Kim SK, Park HK, Choi HS, Yoo KH, Chung JH.

Int Neurourol J. 2016 Dec;20(4):363-370. doi: 10.5213/inj.1632538.269. Epub 2016 Dec 26.

9.

A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.

Oudot A, Oger S, Behr-Roussel D, Caisey S, Bernabé J, Alexandre L, Giuliano F.

BJU Int. 2012 Nov;110(9):1352-8. doi: 10.1111/j.1464-410X.2012.11085.x. Epub 2012 Mar 27.

10.

Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative.

Yang X, Yuan L, Xiong C, Yin C, Ruan J.

J Ethnopharmacol. 2014 Nov 18;157:105-13. doi: 10.1016/j.jep.2014.09.025. Epub 2014 Sep 23.

PMID:
25260581
11.

The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats.

Wu X, Gu Y, Li L.

Toxicol Lett. 2017 Jan 4;265:9-16. doi: 10.1016/j.toxlet.2016.11.011. Epub 2016 Nov 17.

PMID:
27866977
12.

[Effect of PI3K/AKT inhibitor on benign prostate hyperplasia and its mechanism: an experimental study].

Jin P, Wang YH, Peng YG, Hu S, Lu Q, Yang LY.

Zhonghua Nan Ke Xue. 2010 Dec;16(12):1068-75. Chinese.

PMID:
21348195
13.

Sex steroids and epidermal growth factor in benign prostatic hyperplasia (BPH).

Sciarra F.

Ann N Y Acad Sci. 1995 Jun 12;761:66-78.

PMID:
7542859
14.

The overlooked cause of benign prostatic hyperplasia: prostatic urethral angulation.

Cho KS, Kim J, Choi YD, Kim JH, Hong SJ.

Med Hypotheses. 2008;70(3):532-5. Epub 2007 Aug 29.

PMID:
17761390
15.

Mechanisms of inhibition of human benign prostatic hyperplasia in vitro by the luteinizing hormone-releasing hormone antagonist cetrorelix.

Siejka A, Schally AV, Block NL, Barabutis N.

BJU Int. 2010 Nov;106(9):1382-8. doi: 10.1111/j.1464-410X.2010.09215.x.

16.

Labda-8(17),12,14-trien-19-oic acid contained in fruits of Cupressus sempervirens suppresses benign prostatic hyperplasia in rat and in vitro human models through inhibition of androgen and STAT-3 signaling.

Verma V, Sharma V, Singh V, Kumar R, Khan MF, Singh AK, Sharma R, Arya KR, Maikhuri JP, Dalela D, Maurya R, Gupta G.

Phytother Res. 2014 Aug;28(8):1196-203. doi: 10.1002/ptr.5114. Epub 2014 Jan 7.

PMID:
24399792
17.

Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats.

Lee MY, Shin IS, Seo CS, Lee NH, Ha HK, Son JK, Shin HK.

Asian J Androl. 2012 Mar;14(2):320-4. doi: 10.1038/aja.2011.166. Epub 2012 Jan 9.

18.

Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model.

Zhuang Q, Hong F, Shen A, Zheng L, Zeng J, Lin W, Chen Y, Sferra TJ, Hong Z, Peng J.

Int J Oncol. 2012 May;40(5):1569-74. doi: 10.3892/ijo.2012.1326. Epub 2012 Jan 3.

PMID:
22218594
19.

Comprehensive patient evaluation for benign prostatic hyperplasia.

Jepsen JV, Bruskewitz RC.

Urology. 1998 Apr;51(4A Suppl):13-8. Review.

PMID:
9586591
20.

Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(17):1-121. Epub 2006 Aug 1.

Supplemental Content

Support Center